Moving from Promise to Proficiency

Courtesy of Heather Cordell Early Indications: I'd always enjoyed mathematics and statistics at school and then at university. I was interested in applying statis-tical and mathematical methods to scientific and medical problems and got into the area of statistical genetics, basically because I came across an opening to do a DPhil (PhD) in that area. Having gotten into the field, I found genetics to be a source of very interesting statistical problems, as well as providing the opportunity to

Written byHeather Cordell
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Early Indications: I'd always enjoyed mathematics and statistics at school and then at university. I was interested in applying statis-tical and mathematical methods to scientific and medical problems and got into the area of statistical genetics, basically because I came across an opening to do a DPhil (PhD) in that area. Having gotten into the field, I found genetics to be a source of very interesting statistical problems, as well as providing the opportunity to apply my research to important medical problems.

Mentors of Merit: My PhD adviser, John Todd, my postdoctoral advisor, Robert Elston, and my current boss, David Clayton, have all provided invaluable encouragement and guidance. A number of other colleagues, such as Martin Farrall, Dan Weeks, and Jane Olson, have contributed in various ways and at various times to my progress. At secondary school I was greatly encouraged by my mathematics teacher, Judita Cofman. I met John ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies